Press Release Issued from i3screen
- - - i3screen is pleased to announce our new alliance partner – National Drug Screening, Inc. As a value added reseller of the i3screen technology platform and i3screen products and services; National Drug Screening will also provide to its customers over 20 years of expertise in occupational health and drug screening program management.
National Drug Screening, Inc. (NDS) will fulfill an industry need for a state of the art technology software platform combined with Medical Review Officer (MRO) services, drug testing, training and consultation. Services will be offered to small and medium size Third Party Administrator (TPA) operations. NDS will offer one system for scheduling, ordering and processing paperless drug testing using all major SAMHSA laboratories. Clients will save time and money with an efficient electronic process for ordering tests and receiving test results. Point of collection testing programs will provide for negative drug test result to be electronically delivered to the client within minutes.
Joe Reilly, President of National Drug Screening stated “Over the past 20 years in the drug testing industry, I have seen drug testing providers use various software systems for management of drug testing programs. Typically, these providers are not using the full capabilities of the system. It is my goal to provide a software solution combined with expert training and consultative services so that providers can automate their operations with efficient processes which can save the provider and their customer’s both time and money.”
i3screen provides a fully automated web based software technology platform solution for occupational health and drug screening program management. Steve Gatt, CEO of i3screen stated “Our specialized suite of products and services utilize advanced technology in combination with the strength and diversity of allies such as National Drug Screening to set our products apart. This value-added strategic alliance combines our strengths to offer solutions that improve performance for our mutual clients.” Gatt added “Our relationship with NDS will help us to expand our technology platform to many TPA’s allowing them to grow their business with automated and efficient management of the occupational health and drug screening process.”
For more information, please contact:
Dan DiThomas at i3screen at 724-553-5336 / email@example.com
Julie Floriano at National Drug Screening at 321-622-9959 / firstname.lastname@example.org